title: Clomipramine reverses hypoalgesia/hypoesthesia and improved depressive-like behaviors induced by inescapable shock in rats.
abstract: An increased vulnerability to pain complaints, along with a simultaneous increase in experimental pain thresholds, shows the paradoxical phenomenon of pain perception in depressive patients. Clomipramine, a tricyclic antidepressant, could also ameliorate syndromes in chronic pain patients. However, few studies have focused on the effect of antidepressants on experimental pain thresholds. By using a rat model, the learned helplessness paradigm, the present study explored the effect of clomipramine on behavioral deficits and experimental pain thresholds to different stimuli in "helpless" rats. Helpless rats were administered clomipramine (10mg/kg, i.p, b.i.d.) for 5 consecutive days. The depressive-like and anxiety-like behaviors were detected by shuttle box, open field and elevated plus maze test before and after inescapable shock and after medication. The sensitivity to the thermal and mechanical stimuli was also measured by the von Frey hair and Hargreaves test at the indicated time points. Helpless rats displayed shorter total travel distance and fewer rearing times in the open field test and decreased percentage of time spent in the open arms in the elevated plus maze test. In addition, they exhibited significant hypoalgesia/hypoesthesia to mechanical and thermal stimuli. Clomipramine alleviate depressive-like and anxiety-like behaviors and increased the sensitivity to von Frey filament stimuli with no effect on the sensitivity to radiant heat stimuli in helpless rats. These suggested that clomipramine could reverse mechanical but not thermal hypoalgesia/hypoesthesia and simultaneously improved behavioral deficits.
authors: Department of Integrative Medicine and Neurobiology, State Key Lab of Medical Neurobiology, Institutes of Brain Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.
authors: Bing
authors: B
authors: Li
authors: Chang-Jiang
authors: CJ
authors: Yang
authors: Na
authors: N
authors: Yue
authors: Yang
authors: Y
authors: Liu
authors: Jin
authors: J
authors: Yu
authors: Yan-Qing
authors: YQ
authors: Wang
authors: Qiong
authors: Q
authors: Liu
authors: Gen-Cheng
authors: GC
authors: Wu
mesh_terms: D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology* / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D001362:Avoidance Learning; D002997:Clomipramine / Q000494:pharmacology* / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D004597:Electroshock; D006380:Helplessness, Learned; D006358:Hot Temperature; D006987:Hypesthesia / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D017288:Pain Threshold / Q000187:drug effects*; D010812:Physical Stimulation; D051381:Rats; D017208:Rats, Wistar; D014110:Touch
chemical_list: D000929:Antidepressive Agents, Tricyclic; D002997:Clomipramine